0001209191-16-118599.txt : 20160509
0001209191-16-118599.hdr.sgml : 20160509
20160509191414
ACCESSION NUMBER: 0001209191-16-118599
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160505
FILED AS OF DATE: 20160509
DATE AS OF CHANGE: 20160509
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Revance Therapeutics, Inc.
CENTRAL INDEX KEY: 0001479290
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 770551645
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 7555 GATEWAY BLVD.
CITY: NEWARK
STATE: CA
ZIP: 94560
BUSINESS PHONE: 510-742-3400
MAIL ADDRESS:
STREET 1: 7555 GATEWAY BLVD.
CITY: NEWARK
STATE: CA
ZIP: 94560
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Glasheen James Walter
CENTRAL INDEX KEY: 0001532830
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36297
FILM NUMBER: 161633238
MAIL ADDRESS:
STREET 1: TECHNOLOGY PARTNERS
STREET 2: 100 SHORELINE HWY, SUITE 282-B
CITY: MILL VALLEY
STATE: CA
ZIP: 94941
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2016-05-05
0
0001479290
Revance Therapeutics, Inc.
RVNC
0001532830
Glasheen James Walter
C/O TECHNOLOGY PARTNERS
100 SHORELINE HWY, BLDG B, STE 282
MILL VALLEY
CA
94941
1
0
0
0
Stock Option (Right to Buy)
16.63
2016-05-05
4
A
0
8000
0.00
A
2026-05-04
Common Stock
8000
8000
D
The shares subject to the stock option shall vest on the one year anniversary of May 5, 2016, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2014 Equity Incentive Plan) through such vesting date. The stock option represents an annual option grant pursuant to the Issuer's Non-Employee Director Compensation Policy.
/s/ Gordon Ho, Attorney-in-Fact
2016-05-09